Related Experiment Videos
Preimplantation genetic screening and human implantation
Josep Egozcue1, J Santaló, C Giménez
1Department of Cell Biology, Universitat Autònoma de Barcelona, Edifici CS, 08193 Bellaterra, Spain. josep.egozcue@uab.es
Journal of Reproductive Immunology
|June 14, 2002
Summary
Preimplantation genetic screening (PGS) improves implantation rates in older women but has not increased clinical pregnancies. Its effectiveness varies across patient groups, with unknown factors influencing outcomes.
Area of Science:
- Reproductive medicine
- Genetics
- Embryology
Background:
- Preimplantation genetic screening (PGS) is recommended for various infertility cases.
- Indications include advanced maternal age, recurrent ART failures, recurrent abortions, and chromosomal abnormalities.
Purpose of the Study:
- To evaluate the effectiveness of PGS in improving pregnancy and implantation rates across different patient populations.
- To assess the impact of PGS on preventing chromosomal anomalies and reducing trisomic births.
Main Methods:
- Analysis of clinical outcomes following Preimplantation Genetic Screening (PGS).
- Comparison of implantation and clinical pregnancy rates in women undergoing PGS versus standard IVF.
- Stratification of results based on patient demographics and indications for PGS.
Main Results:
- PGS increased implantation rates in older women.
- Clinical pregnancy rates did not improve for older women or those with previous ART failures.
- Pregnancy rates improved in younger women (<35) with recurrent abortions.
- Prognosis remains poor for carriers of balanced rearrangements, and reducing trisomic births in older women is difficult to assess.
Conclusions:
- While PGS can enhance implantation rates, its overall benefit on clinical pregnancy rates is limited and varies by patient group.
- Unknown factors significantly influence the success of PGS, necessitating further research.
- The safety of PGS is not in question, but its clinical utility requires further investigation.